Skip to main content
Clinical Trials/NCT05570370
NCT05570370
Recruiting
Not Applicable

Brain Oscillations, Sleep, and Arousal in Human Cognition - COL

Swiss Federal Institute of Technology1 site in 1 country120 target enrollmentAugust 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer Disease, Early Onset
Sponsor
Swiss Federal Institute of Technology
Enrollment
120
Locations
1
Primary Endpoint
Density of slow-wave activity (SWA) readout from in-ear EEG recordings
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Data collection based on this study will allow us to collect neurophysiological and cognitive data collected from in-ear EEG recordings of the Autosomal dominant alzheimer's disease population in Colombia

Detailed Description

There is solid neurophysiological evidence indicating that abnormal brain rhythms during sleep and noradrenergic dysfunction are core components of cognitive decline and AD onset, and their related pathophysiology. Crucially, irregularities in these neurophysiological mechanisms appear to occur in an asymptomatic and pre-symptomatic stage, but their potential to identify susceptibility for triggering neurodegeneration has yet to be established. Thus, the possibility to identify such risk biomarkers in humans will require the acquisition of large-scale data related direct or indirect measurements of these physiological signatures. A possible key source to obtain such large-scale data related to sleep and noradrenergic function is the assessment of electroencephalographic recordings through non-obtrusive, low-cost, and reliable wearable sensors, alongside the use of advanced neuro-computational algorithms that link brain function and behavioral outcomes of LC function via pupilometry measurements.

Registry
clinicaltrials.gov
Start Date
August 1, 2022
End Date
December 1, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Density of slow-wave activity (SWA) readout from in-ear EEG recordings

Time Frame: Up to 7 nights of at-home recordings

in-ear EEG will be monitored during 7 nights, the aggregated density of SWA over the 7 nights will be compared in both groups (mutation vs non-mutation carrier)

Relative phasic pupilometry responses in exploration vs exploration states in the cognitive task

Time Frame: experimental session at day 1

atent variables of the LC-noradrenergic neuro-computational model based on our cognitive task will indicate the state in wich the participant is (exploration vs exploitation). The relative phasic pupilometry responses in these two states will serve as a proxy of the degree of LC-noradrenergic reaction to these states. The relative reactivity will be compared in both groups (mutation vs non-mutation carriers)

Secondary Outcomes

  • Relative time-frequency decomposition responses in exploration vs exploration states in the cognitive task measured with EEG(experimental session at day 1)

Study Sites (1)

Loading locations...

Similar Trials